New Decision-Making tool aims to prevent bleeding in blood thinner users

NCT ID NCT06401863

Ongoing Disease control Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a computer tool called DDInteract that helps doctors and patients make safer decisions about blood thinners. The tool calculates a person's risk of bleeding and lets them explore 'what if' scenarios. About 3,700 adults on blood thinners will take part across three U.S. clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Shared decision making tool (DDInteract)
What this could lead to: If successful, this tool could help doctors and patients make safer choices about blood thinners, reducing the risk of serious bleeding.
What could go wrong: This is an implementation study, not a drug trial. The tool may not change prescribing habits or reduce bleeding rates as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTICOAGULANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gastrointestinal Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTICOAGULANTS DRUG INTERACTIONS

Contacts and locations

Locations

University of Colorado. School of Medicine

Denver, Colorado, 80045, United States
University of Utah

Salt Lake City, Utah, 84112, United States
Vanderbilt University

Nashville, Tennessee, 37235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.